Capital Research Global Investors’s Neuronetics STIM Stock Holding History

Capital Research Global Investors’s Portfolio STIM Stock Details STIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-847,721	Closed	-$3.81M	–	424
2019 Q4	$3.81M	Sell	847,721 -842,322	-50%	-$5.23M	﹤0.01%	389
2019 Q3	$14M	Buy	1,690,043 +20,000	+1%	+$219K	﹤0.01%	379
2019 Q2	$20.9M	Hold	1,670,043	–	–	0.01%	354
2019 Q1	$25.5M	Buy	1,670,043 +883,143	+112%	+$14.6M	0.01%	364
2018 Q4	$15.2M	Buy	786,900 +312,256	+66%	+$6.85M	0.01%	374
2018 Q3	$15.2M	Buy	474,644 +99,644	+27%	+$3.03M	﹤0.01%	403
2018 Q2	$9.98M	Buy	+375,000	New	+$10.2M	﹤0.01%	412

Other funds holding STIM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

IVM

InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

Capital Research Global Investors's STIM Position: Q1 2020 in Review

Capital Research Global Investors sold out of Neuronetics (STIM) in Q1 2020, closing a stake of 847,721 shares — an estimated $3.81M sold.

Capital Research Global Investors first reported a position in STIM in Q2 2018 and held it in 7 quarters. The position peaked at $25.5M in Q1 2019. 59 funds tracked by Wall St. Rank hold STIM as of Q1 2020.

Capital Research Global Investors reported no remaining Neuronetics position as of Q1 2020 after selling out during the quarter.
Capital Research Global Investors sold 847,721 Neuronetics shares in Q1 2020, an estimated $3.81M.
Capital Research Global Investors first reported a position in Neuronetics in Q2 2018 and held it in 7 quarters.
Capital Research Global Investors's Neuronetics position peaked at $25.5M in Q1 2019.
59 funds tracked by Wall St. Rank held Neuronetics as of Q1 2020.

Based on Capital Research Global Investors's 13F filing for Q1 2020, filed 15 May 2020.